Table 4

Hematologic parameters before therapy and grades 3-4 toxicity during therapy

Toxicity grade at baselineNeutropenia
Anemia
Thrombocytopenia
No. of patients at baselineGrade 3-4 during therapy, nNo. of patients at baselineGrade 3-4 during therapyNo. of patients at baselineGrade 3-4 during therapy, n
Thalidomide       
    0 39   22 1* 
    1  14 1*  
    2  21  
    3    
    4    
    Overall 44  44  44  
Lenalidomide       
    0 39  28 
    1  16 1* 
    2 1* 17  
    3 1*  2* 
    4    
    Overall 41  41  41  
Lenalidomide plus prednisone       
    0 35 18  28 1* 
    1 14  
    2  21  
    3   1* 
    4    
    Overall 40  40  40  
    P  .001  .001  .001 
Toxicity grade at baselineNeutropenia
Anemia
Thrombocytopenia
No. of patients at baselineGrade 3-4 during therapy, nNo. of patients at baselineGrade 3-4 during therapyNo. of patients at baselineGrade 3-4 during therapy, n
Thalidomide       
    0 39   22 1* 
    1  14 1*  
    2  21  
    3    
    4    
    Overall 44  44  44  
Lenalidomide       
    0 39  28 
    1  16 1* 
    2 1* 17  
    3 1*  2* 
    4    
    Overall 41  41  41  
Lenalidomide plus prednisone       
    0 35 18  28 1* 
    1 14  
    2  21  
    3   1* 
    4    
    Overall 40  40  40  
    P  .001  .001  .001 
*

Grade 4 only.

or Create an Account

Close Modal
Close Modal